Shin Poong Pharm. to supply 'Medicurtain' drug to Neopharm in Uzbekistan
Shin Poong Pharm. to supply 'Medicurtain' drug to Neopharm in Uzbekistan
  • Lee Kap-soo
  • 승인 2019.06.27 11:09
  • 댓글 0
이 기사를 공유합니다

Shin Poong Pharm. said on June 26 that it has signed a contract with Neopharm, a Uzbekistan pharmaceutical company, to supply its drug to prevent or reduce post surgical adhesion formation, called "Medicurtain."

According to the company, Shin Poong will exclusively supply Medicurtain to Uzbekistan, and the five-year contract is worth $5.67 million (about 6.6 billion won). Trademarks and patents are owned by Shin Poong.

Medicurtain, developed by Shin Poong with its own technology, is considered to be a unique product developed as a drug to prevent or reduce post surgical adhesion formation after hysteroscopic (gynecology), abdominal, spinal, thyroid and nasal/sinus surgeries.

The company also explained that it is a product that satisfies both medical staff and patients by minimizing side effects from post-operative adhesion, and has both film-type effects and liquid-type convenience.

Medicurtain won the Presidential Award at the Korea Patent Competition and acquired the European Union's CE certification and medical device quality management system certification "ISO 13485" for the first time in Korea.
It has also applied for patents (registered) in the U.S., Japan, Australia, Canada, China, and Europe and is expected to be a global blockbuster product.

"This time, we have set the stage for expansion to large markets such as Russia and Eurasian countries through the first large-scale contract with the Commonwealth of Independent States (CIS) country," a company official said.

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: / Editorial Div. 02-578-0434 / 010-2442-9446. Email:
  • Publisher: Monica Younsoo Chung. Chief Editorial Writer: Kim Hyoung-joong. CEO: Lee Kap-soo. Editor: Jung Yeon-jin.
  • Juvenile Protection Manager: Yeon Choul-woong. IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.